Bausch Health Companies (TSE:BHC – Get Free Report) was upgraded by equities research analysts at Evercore ISI to a “hold” rating in a research note issued to investors on Tuesday, Zacks.com reports.
Separately, Raymond James raised shares of Bausch Health Companies to a “hold” rating in a research report on Wednesday, July 10th.
Get Our Latest Report on Bausch Health Companies
Bausch Health Companies Stock Up 0.8 %
Bausch Health Companies (TSE:BHC – Get Free Report) last announced its quarterly earnings results on Thursday, August 1st. The company reported C$1.22 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of C$1.22. Bausch Health Companies had a negative net margin of 5.12% and a negative return on equity of 2,304.54%. The firm had revenue of C$3.29 billion for the quarter, compared to the consensus estimate of C$3.20 billion. On average, research analysts forecast that Bausch Health Companies will post 5.5472637 EPS for the current fiscal year.
Insider Buying and Selling at Bausch Health Companies
In other Bausch Health Companies news, Senior Officer Seana Lynne Carson sold 13,370 shares of the stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of C$8.38, for a total value of C$112,087.40. Corporate insiders own 11.28% of the company’s stock.
Bausch Health Companies Company Profile
Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.
Featured Articles
- Five stocks we like better than Bausch Health Companies
- Short Selling: How to Short a Stock
- UnitedHealth Group Pulls Back Into a Healthy Buying Opportunity
- Bank Stocks – Best Bank Stocks to Invest In
- Why Alphabet Could Rally 30% Before Christmas
- Business Services Stocks Investing
- J.B. Hunt Stock on the Move: Analysts Forecast Big Gains Ahead
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.